Hemiplegic PatientsNCT06967584
Kinesiotaping on HP Patients Pulmonary Parameters
A study testing Kinesio Taping in people with Hemiplegic Patients and Hemiplegia, run by Istinye University at 1 site in Turkey (Türkiye).
Trial summary
The aim of this study is to investigate whether thoracic kinesio taping contributes to the improvement of pulmonary function, the strengthening of respiratory muscles and the enhancement of overall physical ability in stroke patients with hemiplegia. Read more about this study
- Who is it for?
- Ages 45 to 80 years
- Conditions the study is for
- Hemiplegic Patients, Hemiplegia
- What is being tested?
- Kinesio Taping
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 30 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 11 Nov 2024to 23 Jul 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 45 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- The patients with stroke diagnosis by a neurologist
- 45-80 years old
- Participating to the study in a voluntary basis.
- Patients with clinical setting
- Patient diagnosed at lest stroke attack within 6 months
- They are Medically stable situation
Who cannot join
- Any Other neurological or orthopedic problems that will affect function other than Stroke
- Patients having unstable
- Severe heart diseases like heart failure, unstable hypertension, previous angina pectoris or myocardial infarction
- Skin sensitivity against kinesio tape
- Lesion or incision in the area of kinesio tape application
- Use of analgesics during study period .
- Mental and cognitive disorders that would affect cooperation.
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
İstinye University Bahçeşehir Liv Hospital
Istanbul
About this study
Official title: Effects of Thoracic Kinesio Taping on Pulmonary Functions, Respiratory Muscle Strength and Functional Capacity in Patients With Hemiplegia
The aim of this study is to investigate whether thoracic kinesio taping contributes to the improvement of pulmonary function, the strengthening of respiratory muscles and the enhancement of overall physical ability in stroke patients with hemiplegia. To assess this, a randomized controlled trial will be conducted involving 30 patients aged between 45 and 80 years who have been diagnosed with hemiplegia resulting from a stroke. Participants will be randomly assigned to one of two groups: the Kinesio Taping Group (KTG) or the Sham Kinesio Taping Group (SKTG). The duration of the intervention will be four weeks. During this period, individuals in the KTG will receive thoracic kinesio taping in addition to standard rehabilitation care. In the SKTG, taping will be applied to the same thoracic area but without tension. Measurements will be obtained both before and after the intervention. These assessments will include pulmonary function tests (such as forced vital capacity and forced expiratory volume), evaluations of respiratory muscle strength (specifically maximum inspiratory pressure), and assessments of functional capacity.
Read the detailed description
Hemiplegia, a condition commonly occurring after a stroke, results in paralysis or significant weakness on one side of the body. Although it is primarily recognized for limiting movement in the limbs, hemiplegia can also profoundly affect respiratory function. Many individuals with hemiplegia experience compromised respiratory performance, which can negatively impact overall health, delay recovery, and reduce quality of life. When a stroke affects brain regions responsible for motor control, it may also impair the muscles involved in breathing. Consequently, individuals with hemiplegia often present with weakened respiratory muscles, restricted thoracic mobility, and diminished lung function. These impairments can lead to insufficient oxygen intake, increased susceptibility to respiratory infections such as pneumonia, and prolonged hospitalization. In addition to muscle weakness, patients may develop stiffness in the chest wall and diaphragm, which limits thoracic expansion during inhalation. This restriction can reduce lung capacity and increase the effort required for breathing. Over time, decreased movement in the thoracic region may result in muscle fibrosis and further loss of flexibility. These changes contribute to symptoms such as dyspnea, fatigue, and reduced functional capacity in daily activities. Furthermore, malnutrition-commonly observed in individuals with neurological conditions like stroke-can exacerbate respiratory muscle weakness and increase the risk of respiratory failure. The interplay between poor nutritional status, weakened respiratory muscles, and compromised lung function may create a detrimental cycle that hinders recovery. To improve pulmonary function in patients with hemiplegia, thoracic kinesio taping may be a promising method. This technique involves applying elastic therapeutic tape to the thoracic region to support muscular function, improve posture, enhance breathing mechanics, and increase proprioceptive awareness.
The present study aims to determine whether thoracic kinesio taping can enhance pulmonary function (i.e., lung performance), strengthen respiratory muscles (particularly those involved in inspiration), and improve overall physical capacity in stroke patients with hemiplegia. To evaluate this, a randomized controlled trial will be conducted involving 30 patients between the ages of 45 and 80 who have been diagnosed with hemiplegia resulting from a stroke. All participants will be medically stable and will have experienced a stroke within the previous six months. Patients with significant cardiac or neurological comorbidities, psychiatric conditions impairing communication, or dermatological sensitivities will be excluded to ensure safety and data integrity.
The intervention will span four weeks. During this period, participants will receive thoracic kinesio taping in addition to standard rehabilitation care. In the control group, sham taping will be applied to the same thoracic region without tension. Assessments will be performed before and after the intervention. These will include pulmonary function tests (e.g., forced vital capacity and forced expiratory volume), measurements of respiratory muscle strength (specifically maximum inspiratory pressure, or MIP), and evaluations of functional capacity. It is anticipated that an improvement in MIP may be observed, suggesting a strengthening of inspiratory muscles due to the intervention. No significant changes are expected in maximum expiratory pressure (MEP), which assesses expiratory muscle strength. Any observed improvements in respiratory parameters and daily functional abilities would support the efficacy of thoracic kinesio taping as a supplementary tool in stroke rehabilitation.
This study holds significance by addressing a frequently overlooked component of stroke recovery: respiratory health. Identifying effective strategies to support pulmonary function may enhance recovery outcomes, reduce complications, and promote greater independence in daily life. The results of this study may also inform the development of more comprehensive rehabilitation protocols for individuals with hemiplegia.
- Conditions
- Hemiplegic Patients, Hemiplegia
- Being tested
- Kinesio Taping, Sham Kinesio Taping
- Keywords
- Stroke, Kinesio taping, Chest Physiotherapy, Respiratory test
- Medical subject headings
- Hemiplegia, Stroke
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Kinesio TapingOther
The Kinesio tape will be applied anteriorly and posteriorly along the subcostal region to facilitate the respiratory muscles. Anteriorly, an "I"-shaped Kinesio tape will be applied with the base anchored on the xiphoid process, stretched to 50-75% tension, applied only to the linea alba. The ends of the tape will be applied without tension toward the subcostal curvature. Posteriorly, a second "I"-shaped Kinesio tape will be applied. The base of the tape will be anchored on the spinous process of the 12th thoracic vertebra with 50-75% tension, and the tails will be applied without tension toward the ribs
Sham Kinesio TapingOther
The Kinesio tape will be applied anteriorly and posteriorly along the subcostal region but without tension
| Study group | Role | What they receive |
|---|---|---|
| Kinesio Taping group | Experimental | Not described Receives: Other: Kinesio Taping |
| Sham Kinesio Taping group | Sham comparator | Not described Receives: Other: Sham Kinesio Taping |
What is being measured
The primary outcome is the main question the study is designed to answer.
Forced Vital Capacity (FVC)
Pulmonary function testing will be performed in a sitting position using a portable spirometer according to American Thoracic Society guidelines. Spirometry is a standard pulmonary function test used to assess how effectively the lungs are operating. The test will calculate FVC (The volume delivered during an expiration made as forcefully and completely as possible starting from full inspiration)
Measured: Through study completion, an average of 1 month
Forced Expiratory Volume in the first second (FEV1)
Pulmonary function testing will be performed in a sitting position using a portable spirometer according to American Thoracic Society guidelines. Spirometry is a standard pulmonary function test used to assess how effectively the lungs are operating. The test will calculate FEV1 (The volume delivered in the first second of a FVC maneuver.)
Measured: Through study completion, an average of 1 month
Peak Expiratory Flow (PEF)
Pulmonary function testing will be performed in a sitting position using a portable spirometer according to American Thoracic Society guidelines. Spirometry is a standard pulmonary function test used to assess how effectively the lungs are operating. The test will calculate PEF (The highest forced expiratory flow measured with a peak flow meter. In other word, this measures the maximum speed at which the patient can exhale air.)
Measured: Through study completion, an average of 1 month
Respiratory Muscle Strength
Respiratory muscle strength, including maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP), will be evaluated using an electronic pressure transducer (MicroRPM; Micro Medical Ltd., Kent, United Kingdom). For the MIP measurement, the patient will be seated comfortably. Following a maximal exhalation, the nose will be occluded using a nasal clip, and a maximal inhalation will be performed through a mouthpiece. For the MEP measurement, after a maximal inhalation in the same seated position, the nose will again be closed with a clip, and a maximal exhalation will be carried out through the mouthpiece. Each measurement will be repeated three times, and the highest value will be recorded. Assessments will be performed twice: once at baseline and once at the end of the approximately one-month intervention period.
Measured: Through study completion, an average of 1 month
Functional Capacity
Functional capacity will be assessed using the Functional Bridge Test (FBT). In this test, the patient lies in a supine position on a bed and performs a bridge movement, which involves lifting the hips and extending the trunk against gravity, thereby engaging the hip and trunk extensor muscles. This maneuver is intended to evaluate the postural control function of the proximal lower-extremity and trunk muscles, which are essential for bed mobility. The test is graded on a four-point scale to assess functional capacity:
Grade 1: Difficulty initiating lift-off Grade 2: Insufficient hip elevation Grade 3: Slightly insufficient hip elevation Grade 4: Sufficient hip elevation Assessments will be conducted twice: once at baseline and once at the end of the one-month intervention period.
Measured: Through study completion, an average of 1 month
Secondary outcomes (5)
Symptoms- Dyspnea, Fatigue, pain, cough and sputum
The patient's pain intensity, severity of dyspnea, and cough severity will be evaluated using the Visual Analog Scale (VAS), a tool that helps assess the intensity of sensations such as pain. The VAS consists of a straight line, with one end indicating no pain "0" and the other end representing the worst pain imaginable "10", allowing patients to mark a point that corresponds to their experience. Additionally, the presence of sputum will be evaluated through patient questioning to further assess respiratory symptoms.
Measured: Through study completion, an average of 1 month
Functional Independence Measure
The Functional Independence Measure (FIM) is one of the most highly recommended tools for assessing functional recovery in stroke patients. This tool is considered reliable and has been proven to possess high validity for measuring the functional outcomes of stroke patients. FIM consists of 18 items related to daily activities, with a total score ranging from 18 to 126. Each item is rated on a 7-point scale, ranging from 1 (completely dependent) to 7 (independent), based on the level of independence. A total score of ≤108 indicates the need for assistance or limitations in activities.
Measured: Through study completion, an average of 1 month
Muscle Strength
The muscle strength will assess by using the hand held dynamometer. Muscle strength of shoulder flexors, abductors, elbow flexors, hip flexors, hip extensors and knee extensors will be evaluated.
Measured: Through study completion, an average of 1 month
Grip Strength
JAMAR hand dynamometer will be used to evaluate grip strength. During the grip strength assessment, subjects will instruct to position their hand on their thigh with adduct and neutrally rotated shoulders. The arm being test had the elbow flexed to 90 degrees, while the forearm, wrist, and fingers maintained neutral positions
Measured: Through study completion, an average of 1 month
Muscle Tone
The Muscle Tone will be measured by using Modified Ashworth Scale. Modified Ashworth Scale tool used to measure the increase of muscle tone in stroke patients. Ashworth Scale as a method of grading spasticity while working with stroke. The original Ashworth scale was a 5 point numerical scale that graded spasticity from 0 to 4, with 0 being no resistance and 4 being a limb rigid in flexion or extension.
Measured: Through study completion, an average of 1 month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 May 2025
- Study start11 Nov 2024
- Primary completion23 Jul 2025
- Study completion23 Jul 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Hemiplegic PatientsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- Istinye University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Çiçek Günday, Istinye University
- Investigators
- Roya Soltanalizadeh, Specialist, Study chair, Istinye UniversityYunus Emre Tütüneken, Pt.MSc.PhD, Study chair, Istinye University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06967584
- Sponsor's protocol ID
- 1142025
- Status last verified
- Jul 2025
- First submitted
- 19 Apr 2025
- Last updated
- 25 Jul 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 25 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Thoracic Kinesio Taping on Pulmonary Functions, Respiratory Muscle Strength and Functional Capacity in Patients With Hemiplegia
- ClinicalTrials.gov ID
- NCT06967584
- Acronym / sponsor ID
- 1142025
- Conditions
- Hemiplegic Patients, Hemiplegia
- Keywords
- Stroke, Kinesio taping, Chest Physiotherapy, Respiratory test
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- Istinye UniversityUniversity, hospital or other
- Study start
- 11 Nov 2024 (actual)
- Primary completion
- 23 Jul 2025 (actual)
- Study completion
- 23 Jul 2025 (actual)
- First posted
- 13 May 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to investigate whether thoracic kinesio taping contributes to the improvement of pulmonary function, the strengthening of respiratory muscles and the enhancement of overall physical ability in stroke patients with hemiplegia. To assess this, a randomized controlled trial will be conducted involving 30 patients aged between 45 and 80 years who have been diagnosed with hemiplegia resulting from a stroke. Participants will be randomly assigned to one of two groups: the Kinesio Taping Group (KTG) or the Sham Kinesio Taping Group (SKTG). The duration of the intervention will be four weeks. During this period, individuals in the KTG will receive thoracic kinesio taping in addition to standard rehabilitation care. In the SKTG, taping will be applied to the same thoracic area but without tension. Measurements will be obtained both before and after the intervention. These assessments will include pulmonary function tests (such as forced vital capacity and forced expiratory volume), evaluations of respiratory muscle strength (specifically maximum inspiratory pressure), and assessments of functional capacity.
Detailed description
Hemiplegia, a condition commonly occurring after a stroke, results in paralysis or significant weakness on one side of the body. Although it is primarily recognized for limiting movement in the limbs, hemiplegia can also profoundly affect respiratory function. Many individuals with hemiplegia experience compromised respiratory performance, which can negatively impact overall health, delay recovery, and reduce quality of life. When a stroke affects brain regions responsible for motor control, it may also impair the muscles involved in breathing. Consequently, individuals with hemiplegia often present with weakened respiratory muscles, restricted thoracic mobility, and diminished lung function. These impairments can lead to insufficient oxygen intake, increased susceptibility to respiratory infections such as pneumonia, and prolonged hospitalization. In addition to muscle weakness, patients may develop stiffness in the chest wall and diaphragm, which limits thoracic expansion during inhalation. This restriction can reduce lung capacity and increase the effort required for breathing. Over time, decreased movement in the thoracic region may result in muscle fibrosis and further loss of flexibility. These changes contribute to symptoms such as dyspnea, fatigue, and reduced functional capacity in daily activities. Furthermore, malnutrition-commonly observed in individuals with neurological conditions like stroke-can exacerbate respiratory muscle weakness and increase the risk of respiratory failure. The interplay between poor nutritional status, weakened respiratory muscles, and compromised lung function may create a detrimental cycle that hinders recovery. To improve pulmonary function in patients with hemiplegia, thoracic kinesio taping may be a promising method. This technique involves applying elastic therapeutic tape to the thoracic region to support muscular function, improve posture, enhance breathing mechanics, and increase proprioceptive awareness.
The present study aims to determine whether thoracic kinesio taping can enhance pulmonary function (i.e., lung performance), strengthen respiratory muscles (particularly those involved in inspiration), and improve overall physical capacity in stroke patients with hemiplegia. To evaluate this, a randomized controlled trial will be conducted involving 30 patients between the ages of 45 and 80 who have been diagnosed with hemiplegia resulting from a stroke. All participants will be medically stable and will have experienced a stroke within the previous six months. Patients with significant cardiac or neurological comorbidities, psychiatric conditions impairing communication, or dermatological sensitivities will be excluded to ensure safety and data integrity.
The intervention will span four weeks. During this period, participants will receive thoracic kinesio taping in addition to standard rehabilitation care. In the control group, sham taping will be applied to the same thoracic region without tension. Assessments will be performed before and after the intervention. These will include pulmonary function tests (e.g., forced vital capacity and forced expiratory volume), measurements of respiratory muscle strength (specifically maximum inspiratory pressure, or MIP), and evaluations of functional capacity. It is anticipated that an improvement in MIP may be observed, suggesting a strengthening of inspiratory muscles due to the intervention. No significant changes are expected in maximum expiratory pressure (MEP), which assesses expiratory muscle strength. Any observed improvements in respiratory parameters and daily functional abilities would support the efficacy of thoracic kinesio taping as a supplementary tool in stroke rehabilitation.
This study holds significance by addressing a frequently overlooked component of stroke recovery: respiratory health. Identifying effective strategies to support pulmonary function may enhance recovery outcomes, reduce complications, and promote greater independence in daily life. The results of this study may also inform the development of more comprehensive rehabilitation protocols for individuals with hemiplegia.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Kinesio Taping group | Experimental | Other: Kinesio Taping |
| Sham Kinesio Taping group | Sham comparator | Other: Sham Kinesio Taping |
Who may qualify
- Ages
- 45 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- The patients with stroke diagnosis by a neurologist
- 45-80 years old
- Participating to the study in a voluntary basis.
- Patients with clinical setting
- Patient diagnosed at lest stroke attack within 6 months
Key exclusion criteria (7 listed)
- Any Other neurological or orthopedic problems that will affect function other than Stroke
- Patients having unstable
- Severe heart diseases like heart failure, unstable hypertension, previous angina pectoris or myocardial infarction
- Skin sensitivity against kinesio tape
- Lesion or incision in the area of kinesio tape application
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Kinesio TapingThe Kinesio tape will be applied anteriorly and posteriorly along the subcostal region to facilitate the respiratory muscles. Anteriorly, an "I"-shaped Kinesio tape will be applied with the base anchored on the xiphoid process, stretched to 50-75% tension, applied only to the linea alba. The ends of the tape will be applied without tension toward the subcostal curvature. Posteriorly, a second "I"-shaped Kinesio tape will be applied. The base of the tape will be anchored on the spinous process of the 12th thoracic vertebra with 50-75% tension, and the tails will be applied without tension toward the ribs | Other | Kinesio Taping group |
| Sham Kinesio TapingThe Kinesio tape will be applied anteriorly and posteriorly along the subcostal region but without tension | Other | Sham Kinesio Taping group |
Primary outcome
Forced Vital Capacity (FVC)
Time frame: Through study completion, an average of 1 month
Pulmonary function testing will be performed in a sitting position using a portable spirometer according to American Thoracic Society guidelines. Spirometry is a standard pulmonary function test used to assess how effectively the lungs are operating. The test will calculate FVC (The volume delivered during an expiration made as forcefully and completely as possible starting from full inspiration)
Forced Expiratory Volume in the first second (FEV1)
Time frame: Through study completion, an average of 1 month
Pulmonary function testing will be performed in a sitting position using a portable spirometer according to American Thoracic Society guidelines. Spirometry is a standard pulmonary function test used to assess how effectively the lungs are operating. The test will calculate FEV1 (The volume delivered in the first second of a FVC maneuver.)
Peak Expiratory Flow (PEF)
Time frame: Through study completion, an average of 1 month
Pulmonary function testing will be performed in a sitting position using a portable spirometer according to American Thoracic Society guidelines. Spirometry is a standard pulmonary function test used to assess how effectively the lungs are operating. The test will calculate PEF (The highest forced expiratory flow measured with a peak flow meter. In other word, this measures the maximum speed at which the patient can exhale air.)
Respiratory Muscle Strength
Time frame: Through study completion, an average of 1 month
Respiratory muscle strength, including maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP), will be evaluated using an electronic pressure transducer (MicroRPM; Micro Medical Ltd., Kent, United Kingdom). For the MIP measurement, the patient will be seated comfortably. Following a maximal exhalation, the nose will be occluded using a nasal clip, and a maximal inhalation will be performed through a mouthpiece. For the MEP measurement, after a maximal inhalation in the same seated position, the nose will again be closed with a clip, and a maximal exhalation will be carried out through the mouthpiece. Each measurement will be repeated three times, and the highest value will be recorded. Assessments will be performed twice: once at baseline and once at the end of the approximately one-month intervention period.
Functional Capacity
Time frame: Through study completion, an average of 1 month
Functional capacity will be assessed using the Functional Bridge Test (FBT). In this test, the patient lies in a supine position on a bed and performs a bridge movement, which involves lifting the hips and extending the trunk against gravity, thereby engaging the hip and trunk extensor muscles. This maneuver is intended to evaluate the postural control function of the proximal lower-extremity and trunk muscles, which are essential for bed mobility. The test is graded on a four-point scale to assess functional capacity: Grade 1: Difficulty initiating lift-off Grade 2: Insufficient hip elevation Grade 3: Slightly insufficient hip elevation Grade 4: Sufficient hip elevation Assessments will be conducted twice: once at baseline and once at the end of the one-month intervention period.
5 secondary outcomes
Symptoms- Dyspnea, Fatigue, pain, cough and sputum
Time frame: Through study completion, an average of 1 month
Functional Independence Measure
Time frame: Through study completion, an average of 1 month
Muscle Strength
Time frame: Through study completion, an average of 1 month
Grip Strength
Time frame: Through study completion, an average of 1 month
Muscle Tone
Time frame: Through study completion, an average of 1 month
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Jul 2025.
- Individual participant dataSharing planned: No
Related trials for Hemiplegic Patients
Not yet recruiting
EFFECT OF ROBOTIC GLOVES TRAINING ON UPPER LIMB COORDINATION, SELECTIVE MOTOR CONTROL AND ACTIVITIES OF DAILY LIVING IN CHILDREN WITH HEMIPARETIC CEREBRAL PALSY.
Hemiplegic Cerebral Palsy
Recruiting
Short-Term Effects of Manual Therapy Prior to Neuromotor Therapy in Children With Cerebral Palsy
Cerebral Palsy (CP), Unilateral Spastic Cerebral Palsy
Active, not recruitingObservational study
Focused Intensive Repeated Stepping During Inpatient Rehabilitation Poststroke - A Quality Improvement Project
Stroke, Acute, Gait, Hemiplegic
Active, not recruiting
Virtual Reality Vs Postural Control Training in Children With Cerebral Palsy
Children With Hemiplegic cp
Not yet recruiting
Virtual Reality-Augmented Constraint-Induced Movement Therapy Versus Conventional Constraint-Induced Therapy for Upper Limb Rehabilitation in Children With Unilateral Cerebral Palsy.
Cerebral Palsy Spastic Hemiplegic, Functionnal Neurological Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Roya Soltanalizadeh, Specialist study chair
Istinye University
Yunus Emre Tütüneken, Pt.MSc.PhD study chair
Istinye University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Kinesio Taping in people with Hemiplegic Patients and Hemiplegia, run by Istinye University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 25 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Forced Vital Capacity (FVC) (time frame: Through study completion, an average of 1 month). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jul 2025; AzTrials last refreshed its copy on 31 Oct 2026.